Morphic kept it simple in M&A maneuvers, staying focused on Lilly to reel in $3.2B buyout

Morphic only had eyes for Eli Lilly. While some takeover tales have casts of Shakespearean breadth, Lilly’s $3.2 billion Morphic buyout is a simpler story of two companies gradually closing the gap between their positions before tying the knot.